At Cambridge Consultants, the latest sensing, imaging, data analysis and state-of-the-art engineering techniques are deployed to deliver targeted individualized treatments and disruptive next-generation diagnostic solutions.

We transform the management of chronic and acute diseases through molecular diagnostics and cutting-edge liquid biopsy techniques. 

Individualized treatments   

Diagnostics and medicines are becoming more targeted.

Individualized treatments require cost-effective and targeted approaches to preparing and sampling genetic material and the isolation of specific cells of interest.

Our expertise in microfluidics, single-cell analysis and manipulation, along with experience in deep imaging and data analysis experience enable our clients to create patient-specific therapies. 

Sample preparation 

As more specific and complex diagnostic pathways migrate from research use only (RUO) to in-vitro diagnostic (IVD) or point-of-care (POC) devices, complex lab-based procedures need to be replicated in standalone devices to meet the challenges of decentralized testing.

These systems are varied, but many require understanding of microfluidics and microdroplet manipulation, as well as techniques such as electrowetting, the introduction of shear forces and complex control systems.

Further systems require tight thermal controls, including the Polymerase Chain Reaction (PCR). 

Liquid biopsy and cancer

The ability to monitor patients’ progress through frequent blood tests promises to revolutionize cancer treatment. Here, a blend of engineering, design and digital health expertise is helping clients lead the way in personalized medicine.

A track record developing complex medical devices gives us the experience to use powerful technologies – such as digital PCR and next-generation sequencing – and to create advanced liquid biopsy diagnostic platforms.   

Machine learning and AI   

Large amounts of genomic, molecular, cellular, and patient data can be processed to accelerate the identification of new compounds, treatments, biological targets, pathways and clinical trial participants.

We can deploy world-class machine learning capabilities to develop practical systems for image and data analysis and the detection of patterns in voice, sleep and other physiological markers. 

Life sciences market analysis  

Many companies start with a great life sciences idea then look for funding to develop it. Creating a compelling business case requires a clear understanding of the market need, the limitations of current products and the potential growth of the specific segment.

The strategy consulting team here specializes in primary and secondary market research, technical due diligence for acquisitions and compiling core business case information. Many clients carry out an initial study in order to support further funding rounds.

We can help you at every stage of the technology development lifecycle and take your idea from concept to launch.  

How we work

It is complex, so successful life science and diagnostic device development demands a diverse set of skills. We provide the experience and insight necessary to transform your ideas into fully-realized products ready for manufacture.

Engineering, biology and physics disciplines combine to form tight teams that develop and iterate complex solutions. These are tested in wet labs using biologically relevant models.

By complementing our clients’ own expertise and experience, we are better able to manage development risks. This results in increased confidence, reduced timelines and market-ready products. 

Interested in joining us?

Tech, tools & facilities

Life Science Labs

Life science labs

Our suite of restricted Class II laboratories is specifically designed for handling and experimentation of pharmaceuticals, licensed substances, biological hazards and human samples in a controlled and regulated environment. Our instrumentation rooms are equipped with metrology, microscopy and product test equipment for rigorous verification and quality assurance of prototypes and products.

Synthetic biology lab

Synthetic biology labs

Located in our Cambridge head office, our microbiology lab enables us to genetically modify micro-organisms and characterize them. Our facilities are containment level 2 rated for handling pathogenic strains and our in-house libraries allow rapid modular DNA construct design and assembly. We are particularly interested in building organisms that are biological sensors for healthcare and industrial biotech applications.

Microfluidics lab

Microfluidics lab

Our microfluidics lab is equipped to rapidly prototype Polydimethylsiloxane (PDMS) microfluidic devices in a clean environment. We optically inspect functioning test cartridges with state-of-the-art microscopy, and measure particle size distributions with a Spraytec laser diffraction system.

Optics labs

Optics labs

Our suite optics of labs enables us to build complex and high-precision optical layouts, typically for testing prototype designs and novel techniques prior to deployment. Featuring six high-spec optical benches with configurable interlocked controlled areas for high-power (class 4) laser work and specialist facilities for interferometry, spectroscopy, low-noise fluorescence imaging and photon counting. This space can be split into separate laser-controlled areas, allowing multiple experiments to run simultaneously, giving our optical engineers the capability to develop creative solutions without instrumentation restrictions.

We can help you achieve the seemingly impossible

News & insights


Creating robust bioprocessing scale-down models

May 18, 2021

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

  • Bioinnovation
Press release

Rapid discovery and manufacture of next-generation cell therapies

Jan 21, 2020

Kytopen engages Cambridge Consultants to co-develop alpha Flowfect™ System 


Exploring the potential for non-contact monitoring for sepsis, the quick and costly killer

Jan 17, 2020

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

  • AI & Analytics
  • Connectivity & IoT
  • Digital health
  • Sensing
  • Signal processing
Press release

Leap: The tiny camera that will disrupt intravascular imaging

Oct 9, 2018

‘Leap’ is a watershed moment for intravascular surgery: a single-use, high-definition miniature camera that allows a digital view inside veins and arteries for the first time.

Case studies

AstraZeneca sample containment system

A rapid response to help speed up vital COVID-19 testing

Best in class: molecular diagnostics

The extremely fast polymerase chain reaction (PCR) device we developed has sped up the diagnosis of patients and helped our client maintain its leading position in the molecular diagnostics market. 

Biology-based contaminant monitoring

Developing biology-based sensors as a cost effective, long-term solution for monitoring environmental public health risks

Smart health monitoring wearable

Capturing data and applying machine learning algorithms to better understand stress and deliver more effective drug treatment


Panel discussionSponsor

New Statesman spotlight BioTechnology Conference 2021

Jul 15, 2021

Matthew Jones, principal synthetic biologist will be joining industry experts on a panel to discuss how we can use biotechnology to take the UK towards net zero carbon, and can biotech be used to create a circular economy? 


IPAC-RS Webinar: What is a digital biomarker and why is it important?

Sep 10, 2021

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021. 


Founder Led Biotech Summit 2021

Nov 1, 2021 - Nov 5, 2021

The Founder-Led Biotech Summit is a free virtual event from Nov. 1st - 5th. The event brings together founders, investors, scientists, PhD students, and more from around the globe to drive the founder-led biotech movement that is hosted by Petri and Pillar.

Rethinking Materials 2022 Summary
Panel discussion

Rethinking Materials - Enhancing performance: material innovation disrupting product design

May 5, 2022
Hilton London Tower Bridge

Join us live in London on May 4-5, 2022 for two days of intelligent debate and targeted networking with business leaders from across the value chain.